Email this article 
Science research experience in the use of radiopharmaceuticals at the N.N. Petrov NMRC of Oncology
- Authors: Krzhivitsky P.I.1
-
Affiliations:
- N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
- Issue: Vol 3, No 1S (2021): Supplement
- Pages: 26-31
- Section: Пленарное заседание
- URL: https://journals.eco-vector.com/PharmForm/article/view/71779
- DOI: https://doi.org/10.17816/phf71779
- ID: 71779
Cite item
Full Text
Abstract
Radionuclide diagnostics and therapy with open radionuclide sources are one of the most promising and fast-growing areas of modern oncology. The paper presents the main achievements of the N.N. Petrov National Medical Research Center of Oncology, one of the leading departments of radionuclide diagnostics in Russia. Scientific and clinical results of using the new hybrid device in everyday clinical practice have been submitted. The advantages and opportunities of using hybrid SPECT-CT and PET-CT devices to diagnose different types of cancer, to assess the degree of its spread and to monitor the results of therapy have been demonstrated. The problems associated with the demand for new radiopharmaceuticals in practice have been highlighted. The need to simplify normative documents regulating the use of modern therapeutic radionuclide drugs has been substantiated.
About the authors
Pavel I. Krzhivitsky
N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: krzh@mail.ru
PhD of Medical Sciences, Head of the Department of Radionuclide Diagnostics, radiologist / radiologist, Senior Researcher of the Department of Radiation Oncology and Nuclear Medicine
Russian Federation, 197758,St. Petersburg, Leningradskaya street, 68References
- Nanni C., et al. FDG PET in oncology: a real change in therapeutic strategy? // European Journal of Nuclear Medicine and Molecular Imaging. – 2003. – Vol. 31. – № 2. – P. 340.
- Leitha T., Staudenherz A. Hybrid PET/CT and SPECT/CT Imaging. In: Saba L, editor. Computed Tomography-Clinical applications. – Viena: InTech, 2012. – P. 269–292.
- Israel O., Goldsmith S.J. Hybrid SPECT/CT Imaging in Clinical Practice. – New York: Informa healthcare press, 2006. – P. 15–18.
- Halperin C.E. Principles and Practice of Radiation oncology 6th. Ed. – Philadelphia: Wolters Kluer-Lippincot Williams&Wilkins, 2013. – P. 568–590.
- Тютин Л.А., Станжевский А.А., Рыжкова Д.В. [и др.]. Позитронно-эмиссионная томография с ФДГ и динамическая контрастная магнитно-резонансная томография в диагностике рака молочной железы // Радиология-практика. – 2003. – № 4. – С. 14–19. [Tyutin L.A., Stanzhevskij A.A., Ryzhkova D.V. [i dr.]. Pozitronno-emissionnaya tomografiya s FDG i dinamicheskaya kontrastnaya magnitno-rezonansnaya tomografiya v diagnostike raka molochnoj zhelezy // Radiologiya-praktika. – 2003. – № 4. – S. 14–19. (In Russ.)]
- Ринк П.А. Магнитный резонанс в медицине / пер. с англ. Д. В. Устюжанина; под ред. В. Е. Синицына. – Oxford: Blackwell, Scientific Publications, 1995. – 247 с. [Rink P.A. Magnitnyj rezonans v medicine / per. s angl. D. V. Ustyuzhanina; pod red. V. E. Sinicyna. – Oxford: Blackwell, Scientific Publications, 1995. – 247 s. (In Russ.)]
- Прокоп М., Галански М. Спиральная и многослойная компьютерная томография: учебное пособие: в 2 т. / пер. с англ.; под общ. редакцией А.В. Зубарева и Ш.Ш. Шотемора. – Москва: МЕДпресс-информ, 2006-2007. – Т. 2. – 712 с. [Prokop M., Galanski M. Spiral'naya i mnogoslojnaya komp'yuternaya tomografiya: uchebnoe posobie: v 2 t. / per. s angl.; pod obshch. redakciej A.V. Zubareva i SH.SH. SHotemora. – Moskva: MEDpress-inform, 2006-2007. – T. 2. – 712 s. (In Russ.)].
- Наркевич Б.Я., Костылев В.А. Физические основы ядерной медицины. – Москва: АМФ-Пресс, 2001. – 59 с. [Narkevich B.Ya., Kostylev V.A. Fizicheskie osnovy yadernoj mediciny. – Moskva: AMF-Press, 2001. – 59 s. (In Russ.)]
- Krzhivitskii P.I., Novicov S.N., Kanaev S.V., et al. The use of single-photon emission computed tomography-computed tomography in patients with breast cancer // Nucl Med Comm. – 2019. – Vol. 40. – № 2. – P. 169. doi: 10.1097/mnm.0000000000000954.
- Канаев С.В., Новиков С.Н., Крживицкий С.Н. [и др.] Возможности ОФЭКТ-КТ в диагностике опухолевого поражения подмышечных лимфоузлов у больных раком молочной железы // Вопр. онкол. – 2014. – № 2. – С. 51–56. [Kanaev S.V., Novikov S.N., Krzhivickij S.N. [i dr.] Vozmozhnosti OFEKT-KT v diagnostike opuholevogo porazheniya podmyshechnyh limfouzlov u bol'nyh rakom molochnoj zhelezy // Vopr. onkol. – 2014. – № 2. – S. 51–56. (In Russ.)]. doi: 10.37469/0507-3758-2014-60-2-51-56.
- Рыжков А.Д., Яковлева Л.П., Крылов А.С. [и др.] Преимущество комбинированной ОФЭКТ/КТ в диагностике метастазов в костях // Вестник рентгенологии и радиологии. – 2017. – Т. 98. – № 5. – С. 251–255. [Ryzhkov A.D., Yakovleva L.P., Krylov A.S. [i dr.] Preimushchestvo kombinirovannoj OFEKT/KT v diagnostike metastazov v kostyah // Vestnik rentgenologii i radiologii. – 2017. – T. 98. – № 5. – S. 251–255. (In Russ.)]. doi: 10.20862/0042-4676-2017-98-5-251-255.
- Чернов В.И., Медведева А.А., Синилкин И.Г. [и др.] Опыт разработки инновационных радиофармпрепаратов в Томском НИИ онкологии // Сибирский онкологический журнал. – 2015. – № 2. – С. 45–47. [Chernov V.I., Medvedeva A.A., Sinilkin I.G. [i dr.] Opyt razrabotki innovacionnyh radiofarmpreparatov v Tomskom NII onkologii // Sibirskij onkologicheskij zhurnal. – 2015. – № 2. – S. 45–47. (In Russ.)].
Supplementary files
